• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
  

PubMed=8324732
Nils Brunner, Thomas L. Frandsen, Claus Holst-Hansen, Mian Bei, Erik W. Thompson, Alan E. Wakeling, Marc E. Lippman, Robert Clarke;
MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.
Cancer Res. 53:3229-3232(1993)

PubMed=11078910; DOI=10.1016/S0304-3835(00)00579-6
Gila Lilling, H. Hacohen, Ja Nordenberg, Tami Livnat, Varda Rotter, Yechezkel Sidi;
Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
Cancer Lett. 161:27-34(2000)

PubMed=23868472; DOI=10.1038/ncomms3175; PMCID=PMC3759040
Henrik J. Johansson, Betzabe Chavez Sanchez, Filip Mundt, Jenny Forshed, Aniko Kovacs, Elena Panizza, Lina Hultin-Rosenberg, Bo Lundgren, Ulf Martens, Gyongyver Mathe, Zohar Yakhini ...Show all 18 authors... , Khalil Helou, Kamilla Krawiec, Lena Kanter, Anders Hjerpe, Olle Stal, Barbro K. Linderholm, Janne Lehtio; Show fewer authors
Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer.
Nat. Commun. 4:2175.1-2175.10(2013)